Hyponatraemia: biochemical and clinical perspectives

Area of Science:

• Biochemistry
• Internal Medicine
• Nephrology

Background:

• Hyponatraemia is a frequent biochemical abnormality in 15% of hospital inpatients.
• It is frequently linked to severe illness and poorer patient outcomes.
• Understanding its pathophysiology is crucial for effective management.

Observation:

• Hyponatraemia can be classified as spurious, dilutional, depletional, or redistributional.
• Syndrome of inappropriate antidiuresis (SIAD) and sick cell syndrome present complex diagnostic and therapeutic challenges.
• The significance of 'hyponatraemic symptoms' is debated, potentially related to water overload or the primary disease.

Findings:

• Therapeutic strategies must target the underlying etiology of hyponatraemia.
• Focusing on hyponatraemia symptoms directly may be less effective than addressing the causative factors.
• Aggressive sodium correction via saline infusion risks inducing osmotic demyelination (central pontine myelinolysis).

Implications:

• Accurate diagnosis of hyponatraemia subtypes is essential for appropriate patient care.
• Clinical management should prioritize addressing the primary disease process over symptomatic treatment.
• Awareness of iatrogenic risks, such as osmotic demyelination, is critical during fluid and electrolyte management.